Underwood, E. A.
Jerzak, K. J.
Lebovic, G.
Rochon, P. A.
Elser, C.
Pritchard, K. I.
Tierney, M. C. http://orcid.org/0000-0003-1400-4371
Funding for this research was provided by:
Sunnybrook Alternative Funding Plan Association (Innovation Fund)
Sunnybrook Alternative Funding Plan Association (Innovation Fund)
Canadian Federation of University Women (Memorial Fellowship)
University of Toronto (Ontario Graduate Scholarship)
Department of Family and Community Medicine, University of Toronto (Clinician Scientist Award)
Retired Teachers of Ontario (Chair in Geriatric Medicine)
Article History
Received: 24 May 2018
Accepted: 10 December 2018
First Online: 4 January 2019
Compliance with ethical standards
:
: K.I.P. has served in consulting and advisory roles for and received honoraria and travel support from AstraZeneca, Pfizer, Roche, Amgen, Novartis, and Eisai. K.J.J has served as a consultant for and/or attended advisory boards for Genomic Health Inc., Novartis, Purdue Pharma and Roche. No other authors have any conflicts of interest to report. M.C.T has full control of all primary data and agrees to allow the journal to review the data if requested.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.